Publisher
Japanese Association of Rehabilitation Medicine
Reference12 articles.
1. 1) Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) ：WHO classification of tumours of the central nervous system. in Bosman FT, Jaffe ES, Lakhani SR, Ohgaki H (eds) ：World Health Organization Classification of Tumours (Revised 4th Edition). IARC Press Lyon, 2016：pp 7-13
2. 2) The Committee of Brain Tumor Registry of Japan：Report of Brain Tumor Registry of Japan (2005-2008) 14th Edition. Neurol Med Chir (Tokyo) 2017；57：9-102
3. 3) Choi C, Ganji SK, DeBerardinis RJ, Hatanpaa KJ, Rakheja D, Kovacs Z, Yang XL, Mashimo T, Raisanen JM, Marin-Valencia I, Pascual JM, Madden CJ, Mickey BE, Malloy CR, Bachoo RM, Maher EA：2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med 2012；18：624-629
4. 5) Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS：An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011；115：3-8
5. 6) Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO；European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups；National Cancer Institute of Canada Clinical Trials Group：Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005；352：987-996
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献